Discover a life-changing experience
University of the Year for Student Experience
The Times Good University Guide 2020
Scotland's best place to live
The Sunday Times Best Places to Live guide 2019
Top 20 worldwide for Sustainable Development
The Times Higher Education University Impact Rankings 2019
15th in the world for weighted citations
2019 CWTS Leiden Rankings
Research at Dundee
University partners with Bukwang Pharmaceutical Company to develop new drug treatment for Parkinson’s disease
The University of Dundee‘s Drug Discovery Unit (DDU) has announced a multi-million-pound partnership with Korean-based Bukwang Pharmaceutical Company in a bid to develop a new drug treatment for Parkinson’s disease. This announcement builds upon existing drug discovery partnerships the DDU has with Takeda and GSK.
Our Drug Discovery Unit has announced a partnership with Takeda, Japan’s largest pharmaceutical company, to develop possible new therapeutic treatments for tau pathology, an underlying feature in several forms of neurodegeneration including Alzheimer’s disease.
- Inter-microbial warfare may help overcome antimicrobial resistance 17 September 2019
- ‘Forgotten cancer’ to be tackled by Dundee scientists 12 September 2019
- BBC Watchdog Live showcases University smoke alarm research 12 September 2019
Your browser sent a request that this server could not understand.